Two Vasopressin Type 2 Receptor Gene Mutations R143P and ΔV278 in Patients with Nephrogenic Diabetes Insipidus Impair Ligand Binding of the Receptor

1995 ◽  
Vol 211 (3) ◽  
pp. 967-977 ◽  
Author(s):  
H. Tsukaguchi ◽  
H. Matsubara ◽  
Y. Mori ◽  
Y. Yoshimasa ◽  
T. Yoshimasa ◽  
...  
Keyword(s):  
Ligand Binding ◽  
Diabetes Insipidus ◽  
Nephrogenic Diabetes Insipidus ◽  
Receptor Gene ◽  
Gene Mutations

Novel Vasopressin Type 2 (AVPR2) Gene Mutations in Brazilian Nephrogenic Diabetes Insipidus Patients

2006 ◽  
Vol 10 (3) ◽  
pp. 157-162 ◽  
Author(s):  
W.L. Boson ◽  
T. Della Manna ◽  
D. Damiani ◽  
D.M. Miranda ◽  
M.R. Gadelha ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Nephrogenic Diabetes Insipidus ◽  
Gene Mutations

Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region

Genomics ◽  
1992 ◽  
Vol 13 (4) ◽  
pp. 1350-1352 ◽  
Author(s):  
A.M.W. van den Ouweland ◽  
M.T. Knoop ◽  
V.V.A.M. Knoers ◽  
P.W.B. Markslag ◽  
M. Rocchi ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Nephrogenic Diabetes Insipidus ◽  
Receptor Gene

scholarly journals A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.

1996 ◽  
Vol 7 (3) ◽  
pp. 410-414 ◽  
Author(s):  
K Yokoyama ◽  
A Yamauchi ◽  
M Izumi ◽  
T Itoh ◽  
A Ando ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Arginine Vasopressin ◽  
Nephrogenic Diabetes Insipidus ◽  
Receptor Gene ◽  
Single Amino Acid ◽  
Intracellular Camp ◽  
V2 Receptor ◽  
V2 Receptor Gene ◽  
Type Receptor

In this study, a mutation in vasopressin Type 2 receptor (V2R) in a patient with hereditary nephrogenic diabetes insipidus (NDI) has been identified and characterized. The sequencing of the V2R gene from the patient revealed that there was a missense mutation (TAT to TGT) resulting in the substitution of 205Tyr for Cys in the putative third extracellular domain. The expression analysis in COS cells showed that the binding affinity of the mutant receptor (KD = 19.8 nM) for arginine vasopressin was much lower than that of the wild-type receptor (KD = 1.8 nM) so that intracellular cAMP production stimulated by arginine vasopressin was impaired in cells with the mutant V2R. From these results, it was concluded that the single amino-acid substitution of V2R is responsible for this familial disease.

The vasopressin type 2 receptor gene. Chromosomal localization and its role in nephrogenic diabetes insipidus

1993 ◽  
Vol 45 (1-2) ◽  
pp. 67-71 ◽  
Author(s):  
Anita Seibold ◽  
Walter Rosenthal ◽  
Daniel G. Bichet ◽  
Mariel Birnbaumer
Keyword(s):  
Diabetes Insipidus ◽  
Nephrogenic Diabetes Insipidus ◽  
Chromosomal Localization ◽  
Receptor Gene

Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus

1992 ◽  
Vol 2 (2) ◽  
pp. 99-102 ◽  
Author(s):  
Ans M.W. van den Ouweland ◽  
Jos C.F.M. Dreesen ◽  
Marian Verdijk ◽  
Nine V.A.M. Knoers ◽  
Leo A.H. Monnens ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Nephrogenic Diabetes Insipidus ◽  
Receptor Gene

scholarly journals Congenital nephrogenic diabetes insipidus accompanied with central nephrogenic diabetes secondary to pituitary surgery -a case report

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Wei Zhang ◽  
Yimin Shen ◽  
Yuezhong Ren ◽  
Yvbo Xin ◽  
Lijun Wang
Keyword(s):  
Diabetes Insipidus ◽  
Nephrogenic Diabetes Insipidus ◽  
Direct Detection ◽  
Urine Volume ◽  
Pituitary Surgery ◽  
Accurate Method ◽  
Heterozygous Mutation ◽  
Case Presentation ◽  
Congenital Nephrogenic Diabetes Insipidus

Abstract Background Diabetes insipidus (DI) can be a common cause of polydipsia and polyuria. Here, we present a case of congenital nephrogenic diabetes insipidus (CNDI) accompanied with central diabetes insipidus (CDI) secondary to pituitary surgery. Case presentation A 24-year-old Chinese woman came to our hospital with the complaints of polydipsia and polyuria for 6 months. Six months ago, she was detected with pituitary apoplexy, and thereby getting pituitary surgery. However, the water deprivation test demonstrated no significant changes in urine volume and urine gravity in response to fluid depression or AVP administration. In addition, the genetic results confirmed a heterozygous mutation in arginine vasopressin receptor type 2 (AVPR2) genes. Conclusions She was considered with CNDI as well as acquired CDI secondary to pituitary surgery. She was given with hydrochlorothiazide (HCTZ) 25 mg twice a day as well as desmopressin (DDAVP, Minirin) 0.1 mg three times a day. There is no recurrence of polyuria or polydipsia observed for more than 6 months. It can be hard to consider AVPR2 mutation in female carriers, especially in those with subtle clinical presentation. Hence, direct detection of DNA sequencing with AVPR2 is a convenient and accurate method in CNDI diagnosis.

Sign in / Sign up

Export Citation Format

Share Document